McConnell's Hemp Rewrite Puts $28B THC Industry on Deadline

The provision ended the loophole that built the market

McConnell's language rewrote the federal definition of hemp, and the intoxicating-product market the 2018 Farm Bill accidentally created now sits outside it.

The 2018 Farm Bill legalized hemp as cannabis containing no more than 0.3% delta-9 THC by dry weight. Manufacturers read that as a green light. Delta-8 THC, THCA flower, and infused gummies and drinks all flowed through it, sold at gas stations and smoke shops with no age gates in many states.

McConnell, the Kentucky Republican who championed hemp legalization in 2018, led the fix. The provision rode in the spending package signed in November 2025 (H.R. 5371). It changed the test in two ways:

• Finished hemp products are capped at 0.4 mg of total THC per container.
• Synthesized cannabinoids no longer qualify as hemp.

Congress built in a one-year runway. That runway is nearly gone. Compliance comes due roughly mid-November 2026, about six weeks from now.

The cap is a ban in practice, and $28 billion is exposed

The cleanest read on the 0.4 mg cap is that it isn't a restriction on intoxicating hemp products but a prohibition of them.

Fortune put the size of the exposed industry at $28 billion. Consider what a single serving looks like. A 10 mg THC beverage, a common dose in the category, carries 25 times the allowed amount for an entire container. A multi-serving gummy jar isn't close.

The math is brutal.

Exposure runs up and down the supply chain. Hemp farmers who pivoted to high-cannabinoid cultivars, extractors converting CBD into other cannabinoids, beverage brands, and the retailers who stocked them all face the same cliff. CBD products with trace THC can likely survive. Intoxicating products can't.

No surprise here. The industry has known the date for almost a year. Many operators bet that Congress would blink, and that bet looks worse each week the calendar runs.

What operators and investors should watch before the deadline

The outcome now depends on whether Congress delays the effective date, replaces the ban with a regulatory framework, or lets it take hold.

A signal that the bill's text isn't moving would be the most important indicator. Hemp trade groups have pushed for a regulate-don't-ban approach with age limits, testing, and potency standards. Nothing in the Fortune report suggests that effort has produced a law, and the deadline doesn't move without one.

Four variables matter for anyone with money or inventory at stake:

1. Legislative action. A delay or a replacement framework would need to clear both chambers before the November date to matter.
2. Enforcement posture. Federal agencies, including the FDA and DEA, will decide how aggressively they police retail shelves after the effective date. Enforcement priorities, not statutory text, will set the real timeline.
3. State markets. States with licensed adult-use programs, such as California and Ohio, are the obvious landing spot for displaced demand. Licensed operators carry 280E tax burdens and compliance costs that hemp brands never did, so the shift won't be painless for consumers or prices.
4. Inventory and contracts. Operators holding intoxicating hemp stock face a sell-through window that closes in weeks. Wholesale agreements written before November 2025 may need renegotiating.

For full background on this story, see the CannIntel topic hub on the federal hemp loophole.

Investors should treat the sector as split in two. Companies with cannabinoid-neutral revenue, such as CBD, fiber, and food-grade hemp, can absorb the change. Companies whose revenue depends on THC potency can't, unless they hold or can acquire state cannabis licenses.

The next signal: whether lawmakers attach a delay or a regulatory framework to must-pass legislation before mid-November. If they don't, the shelves change on the deadline.